Adverse event with first-dose perindopril in congestive heart failure [7]

Lancet

Volumn 349, Issue 9066, 1997, Pages 1671-1672

  Bagger, Jens Peder ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PERINDOPRIL;

ADULT; BLOOD PRESSURE; CASE REPORT; CONGESTIVE HEART FAILURE; HUMAN; HYPOTENSION; LETTER; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; VISUAL DISORDER;

EID: 0030924857     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62638-4     Document Type: Article

References (5)

1. MacFadyen RJ, Lees KR, Reid JL. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J 1991; 66: 206-11.
2. Opie LH, ed. Angiotensin converting enzyme inhibitors: scientific basis for clinical use. New York: Author's Publishing House, 1992: 173-76, 194-202.
3. Hasford J, Bussmann WD, Delius W, Koepcke W, Lehmann K, Weber E. First dose hypotension with enalapril and prazosin in congestive heart failure. Int J Cardiol 1991; 31: 287-94.
4. Kostis JB, Shelton BJ, Yusuf S, et al. Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the studies of left ventricular dysfunction. Am Heart J 1994; 128: 358-64.
5. Cleland JG, Dargie HJ, McAlpine H, et al. Severe hypotension after first dose of enalapril in heart failure. BMJ 1985; 291: 1309-12.